Xstrahl to Showcase Radiant Aura at 2024 Congress of Clinical Dermatology

May 28, 2024

Xstrahl to Showcase Radiant™ Aura at 2024 Congress of Clinical Dermatology, Amelia Island, FL
Radiant Aura expands office-based radiation therapy treatment options for patients with non-melanoma skin cancers and keloid scarring



Radiant Aura is the only dual modality surface radiation therapy system that enables you to choose either electronic brachytherapy or SRT based on the needs of your patients.

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the 2024 Congress of Clinical Dermatology at The Ritz-Carlton, Amelia Island from May 30 to June 2, 2024. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.

“We are thrilled that Radiant Aura is available to support the delivery of office-based radiation therapy for patients with NMSC when surgery is not possible, contraindicated, or simply not preferred due to cosmetic concerns,” said Adrian Treverton, CEO of Xstrahl.

Radiant Aura is the painless non-surgical skin cancer treatment alternative.
· Office-based treatment
· Approved for both NMSC and keloid scarring
· Compact and designed for dermatology
· Dual modality for superficial radiation therapy (SRT) and electronic brachytherapy (eBt)
· Easy to install and maneuver
· Great patient treatment acceptance
· Excellent clinical outcomes and cure rates
· Established reimbursement

Visit Xstrahl at the 2024 Congress of Clinical Dermatology at The Ritz-Carlton, Amelia Island from May 30 to June 2, 2024.

To be placed on the VIP List for private events at the conference, please email kellywithers@xstrahl.com

# # #

For further information, please contact:
Kelly Withers, National Sales Director
Cell: 602-509-4990 or e-mail: kellywithers@xstrahl.com

About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.

To learn more about Radiant Aura, visit www.radiant-therapy.com
To learn more about all Xstrahl clinical and research systems, visit www.xstrahl.com



Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts